The Role of Galectin-3 in Stellate Cell Activation and Liver Fibrosis

被引：0

作者：

Jiang, Joy X. ^{[1
]}

Chen, Xiangling ^{[1
]}

Fukada, Hiroo ^{[1
]}

Hsu, Dan K. ^{[2
]}

Liu, Fu-tong ^{[2
]}

Toeroek, Natalie J. ^{[1
]}

机构：

[1] UC Davis Med Ctr, Div Gastroenterol & Hepatol, Dept Internal Med, 4635 2nd Ave,Suite 1001, Sacramento, CA 95817 USA

[2] UC Davis Med Ctr, Dept Dermatol, Sacramento, CA 95817 USA

来源：

GALECTINS AND DISEASE IMPLICATIONS FOR TARGETED THERAPEUTICS | 2012年 / 1115卷

关键词：

GROWTH-FACTOR-BETA; APOPTOTIC BODIES; PHAGOCYTOSIS; PROLIFERATION; MOLECULE; ADHESION; OXIDASE;

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Gal3 (galectin-3) has been known to be involved in the regulation of kidney, lung and liver fibrosis. We have reported a novel mechanism by which Gal3 contributes to fibrogenesis. Extracellular Gal3 is required for tethering of apoptotic bodies by HSC via cross-linking with integrin alpha v beta 3, and consequently promoting HSC activation. On the other hand, phagocytosis induces Gal3 production by both HSC and Kupffer cells. Taken together, Gal3 may become a therapeutic target for antifibrogenic strategy.

引用

页码：391 / +

页数：3

共 50 条

[31] Galectin-3 levels in children with cystic fibrosis
Dilber Ademhan Tural
Nagehan Emiralioglu
Senay Akin
Didem Alboga
Beste Ozsezen
Halime Nayir Buyuksahin
Ismail Guzelkas
Merve Kasikci
Birce Sunman
Irem Gungor
Ebru Yalcin
Deniz Dogru
Nural Kiper
Ali Haydar Demirel
Ugur Ozcelik
European Journal of Pediatrics, 2024, 183 : 2333 - 2342
[32] GALECTIN-3 IN REJECTION AND FIBROSIS OF THE TRANSPLANTED HEART
Shevchenko, O. P.
Ulybysheva, A. A.
Gichkun, O. E.
Mozheiko, N. P.
Stakhanova, E. A.
Kvan, V. S.
Shevchenko, A. O.
VESTNIK TRANSPLANTOLOGII I ISKUSSTVENNYH ORGANOV, 2019, 21 (03): : 62 - 68
[33] Galectin-3, Cardiac Function, and Fibrosis Reply
Frunza, Olga
Russo, Ilaria
Shinde, Arti V.
Su, Ya
Frangogiannis, Nikolaos G.
AMERICAN JOURNAL OF PATHOLOGY, 2016, 186 (08): : 2234 - 2235
[34] Galectin-3 antagonists with therapeutic implications in fibrosis
Nilsson, Ulf
Leffler, Hakon
Schambye, Hans
Mackinnon, Alison
Sethi, Tariq
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 249
[35] PENTOXIFYLLINE ATTENUATES ESTABLISHED LIVER FIBROSIS AND HEPATIC STELLATE CELL ACTIVATION IN RAT LIVER FIBROSIS
Mas, Mehmet R.
Bilgin, Gokhan
Karslioglu, Yildirim
Comert, Bilgin
Ozsari, Levent
Tasci, Ilker
Mas, Nuket
Isik, Ahmet T.
Uzunalimaglu, Ozden
HEPATOLOGY, 2008, 48 (04) : 929A - 929A
[36] Galectin-3 promotes fibrosis in ovarian endometriosis
Yang, Guimin
Deng, Yupeng
Cao, Guangming
Liu, Chongdong
PEERJ, 2024, 12
[37] Galectin-3 levels in children with cystic fibrosis
Ademhan Tural, Dilber
Emiralioglu, Nagehan
Akin, Senay
Alboga, Didem
Ozsezen, Beste
Nayir Buyuksahin, Halime
Guzelkas, Ismail
Kasikci, Merve
Sunman, Birce
Gungor, Irem
Yalcin, Ebru
Dogru, Deniz
Kiper, Nural
Demirel, Ali Haydar
Ozcelik, Ugur
EUROPEAN JOURNAL OF PEDIATRICS, 2024, 183 (05) : 2333 - 2342
[38] Galectin-3 Concentration in Liver Diseases
Gudowska, Monika
Gruszewska, Ewa
Cylwik, Bogdan
Panasiuk, Anatol
Rogalska, Magdalena
Flisiak, Robert
Szmitkowski, Maciej
Chrostek, Lech
ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2015, 45 (06): : 669 - 673
[39] PTPRO-Associated Hepatic Stellate Cell Activation Plays a Critical Role in Liver Fibrosis
Zhang, Xudong
Tan, Zhongming
Wang, Youjing
Tang, Junwei
Jiang, Runjiu
Hou, Jiajie
Zhuo, Han
Wang, Xiaochen
Ji, Jie
Qin, Xihu
Sun, Beicheng
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2015, 35 (03) : 885 - 898
[40] Galectin-3 and Severity of Liver Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease
Sotoudeheian, Mohammadjavad
PROTEIN AND PEPTIDE LETTERS, 2024, 31 (04): : 290 - 304

← 1 2 3 4 5 →